Search research articles
Contact Us
Filters
Showing results (201-210 of 216) with videos related to
Page
of 22
Sort By:
Brain : a Journal of Neurology
|
March 1, 1997
Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Pedigree but not mutation specific age at onset provides evidence for a further genetic factor
N C Fox, A M Kennedy, R J Harvey, et al.
Neurology
|
July 10, 2009
Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study
A Okello, J Koivunen, P Edison, et al.
Archives of Neurology
|
June 19, 2001
Autopsy-confirmed familial early-onset Alzheimer disease caused by the l153V presenilin 1 mutation
J C Janssen, P L Lantos, N C Fox, et al.
Neurology
|
May 11, 2005
The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2
H H Klünemann, B H Ridha, L Magy, et al.
Annals of Neurology
|
August 1, 1996
Amyloid beta protein (Abeta) deposition in chromosome 14-linked Alzheimer's disease: predominance of Abeta42(43)
D M Mann, T Iwatsubo, N J Cairns, et al.
Archives of Neurology
|
November 16, 2001
The genetic and pathological classification of familial frontotemporal dementia
H R Morris, M N Khan, J C Janssen, et al.
Alzheimer Disease and Associated Disorders
|
January 1, 1997
Protocols to demonstrate slowing of Alzheimer disease progression. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. The Disease Progression Sub-Group
N Bodick, F Forette, D Hadler, et al.
AJNR. American Journal of Neuroradiology
|
May 15, 2007
Magnetization transfer ratio in Alzheimer disease: comparison with volumetric measurements
B H Ridha, M R Symms, D J Tozer, et al.
Lancet (London, England)
|
January 29, 1999
Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples
A F Hill, R J Butterworth, S Joiner, et al.
Experimental Neurology
|
December 17, 2009
An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levels
A Petzold, M D Chapman, S Schraen, et al.
Page
of 22
Search research articles
Search
Showing results (201-210 of 216) with videos related to
Sort By:
Page
of 22
Brain : a Journal of Neurology
|
March 1, 1997
Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Pedigree but not mutation specific age at onset provides evidence for a further genetic factor
N C Fox, A M Kennedy, R J Harvey, et al.
Neurology
|
July 10, 2009
Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study
A Okello, J Koivunen, P Edison, et al.
Archives of Neurology
|
June 19, 2001
Autopsy-confirmed familial early-onset Alzheimer disease caused by the l153V presenilin 1 mutation
J C Janssen, P L Lantos, N C Fox, et al.
Neurology
|
May 11, 2005
The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2
H H Klünemann, B H Ridha, L Magy, et al.
Annals of Neurology
|
August 1, 1996
Amyloid beta protein (Abeta) deposition in chromosome 14-linked Alzheimer's disease: predominance of Abeta42(43)
D M Mann, T Iwatsubo, N J Cairns, et al.
Archives of Neurology
|
November 16, 2001
The genetic and pathological classification of familial frontotemporal dementia
H R Morris, M N Khan, J C Janssen, et al.
Alzheimer Disease and Associated Disorders
|
January 1, 1997
Protocols to demonstrate slowing of Alzheimer disease progression. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. The Disease Progression Sub-Group
N Bodick, F Forette, D Hadler, et al.
AJNR. American Journal of Neuroradiology
|
May 15, 2007
Magnetization transfer ratio in Alzheimer disease: comparison with volumetric measurements
B H Ridha, M R Symms, D J Tozer, et al.
Lancet (London, England)
|
January 29, 1999
Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples
A F Hill, R J Butterworth, S Joiner, et al.
Experimental Neurology
|
December 17, 2009
An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levels
A Petzold, M D Chapman, S Schraen, et al.
Page
of 22